Heidelberg Pharma AG (HPHA) | WebDisclosure

Basculer en Français

8302	Companies
115114	Keywords
55444	Articles
62529	Press releases

Home
Companies
Heidelberg Pharma AG

BRIEF

published on 04/25/2024 at 07:26, 6 months 26 days ago

Heidelberg Pharma AG publie ses résultats financiers et ses progrès opérationnels pour le premier trimestre 2024

Performance Financière Nomination Du PDG Heidelberg Pharma SA Essai Clinique HDP-101 Développement Du Pipeline ADC
BRIEF

published on 04/25/2024 at 07:26, 6 months 26 days ago

Heidelberg Pharma AG Reports on Q1 2024 Financials and Operational Progress

Financial Performance CEO Appointment Heidelberg Pharma AG HDP-101 Clinical Trial ADC Pipeline Development
PRESS RELEASE

published on 04/25/2024 at 07:21, 6 months 26 days ago

Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2024
Heidelberg Pharma AG reports on its interim management statement for the first three months of 2024, including first efficacy data from a clinical trial and successful financing activities

Clinical Trial Heidelberg Pharma AG ADC Pipeline Interim Statement Financing Activities
BRIEF

published on 04/05/2024 at 09:35, 7 months 16 days ago

Heidelberg Pharma organisera un webinaire R&D pour partager de nouvelles informations sur la recherche sur le cancer

Heidelberg Pharma HDP-101 Myélome Multiple ADC Webinaire R&D
BRIEF

published on 04/05/2024 at 09:35, 7 months 16 days ago

Heidelberg Pharma to Convene R&D Webinar to Share New Cancer Research Insights

Heidelberg Pharma HDP-101 Multiple Myeloma ADCs R&D Webinar
PRESS RELEASE

published on 04/05/2024 at 09:30, 7 months 16 days ago

Heidelberg Pharma to host R&D Webinar following novel data presented at AACR
Heidelberg Pharma AG to host R&D Webinar on 23 April 2024 featuring leading Key Opinion Leaders after presenting novel data at AACR. Event focuses on ADC technologies for cancer treatment

Cancer Treatment Heidelberg Pharma AG R&D Webinar ADC Technologies AACR
BRIEF

published on 03/27/2024 at 09:06, 7 months 25 days ago

Heidelberg Pharma obtient la désignation de médicament orphelin par la FDA pour le HDP-101 dans le traitement du myélome multiple

FDA Heidelberg Pharma Désignation De Médicament Orphelin HDP-101 Myélome Multiple
BRIEF

published on 03/27/2024 at 09:06, 7 months 25 days ago

Heidelberg Pharma Obtains FDA Orphan Drug Designation for HDP-101 in Multiple Myeloma Treatment

FDA Orphan Drug Designation Heidelberg Pharma HDP-101 Multiple Myeloma
PRESS RELEASE

published on 03/27/2024 at 09:01, 7 months 25 days ago

Heidelberg Pharma granted orphan drug designation by FDA for its proprietary ATAC candidate HDP-101
Heidelberg Pharma granted orphan drug designation by FDA for its ATAC candidate HDP-101, targeting multiple myeloma. The designation provides significant benefits for the development and potential marketing of the drug

FDA Orphan Drug Designation Heidelberg Pharma Multiple Myeloma ATAC Candidate
BRIEF

published on 03/25/2024 at 07:15, 7 months 27 days ago

Heidelberg Pharma AG présente ses solides performances pour 2023 et ses faits saillants financiers

Résultats Financiers 2023 Technologie CAN Heidelberg Pharma SA Essai HDP-101 Thérapie Contre Le Cancer

Accesswire

Published on 11/21/2024 at 21:50, 19 minutes ago

Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 1 hour 54 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 1 hour 59 minutes ago

For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform
Published on 11/21/2024 at 20:00, 2 hours 9 minutes ago

Victory for New York Homeowners: Petroff Amshen LLP Blocks Lender’s Repeated Foreclosure Attempt
Published on 11/21/2024 at 19:25, 2 hours 44 minutes ago

Ibero Mining Reports Results From Deep Undercut Drill Hole At Miguel Vacas Mine

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 19:01, 3 hours 8 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 3 hours 33 minutes ago

Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 4 hours 11 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 4 hours 18 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 4 hours 18 minutes ago

LIGHTON annonce le vif succès de son introduction en Bourse sur Euronext Growth Paris.

Les Echos

Published on 11/21/2024 at 06:58, 15 hours 11 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 15 hours 11 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 15 hours 11 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 1 day 2 hours ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 1 day 2 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE